AAV9-CMV-BMI-1-RING1B
AAV9-CMV-BMI-1-RING1B has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Apr 1, 2022: “Bmi-1-RING1B prevents GATA4-dependent senescence-associated pathological cardiac hypertrophy by promoting autophagic degradation of GATA4”.
1 paper studies it1 findingUpdated
See all 1 papers on AAV9-CMV-BMI-1-RING1B
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Government of Jiangsu Province and 2 more
- Animals1
What did studies of AAV9-CMV-BMI-1-RING1B find?
1Studies of AAV9-CMV-BMI-1-RING1B measured one outcome, gata4.
gata4
downin mice1
1 study
gata4
downin mice1
AAV9-CMV-BMI-1-RING1B decreases gata4 in mice (via selective autophagy).
Animalsvia selective autophagyheart
Latest
Clinical and Translational Medicine
Bmi-1-RING1B prevents GATA4-dependent senescence-associated pathological cardiac hypertrophy by promoting autophagic degradation of GATA4
Experiments in miceAutophagy